- Patient Involvement in the Development and Safe Use of Medicines (CIOMS XI);
- Benefit-Risk Balance for Medicinal Products (CIOMS XII) - this will be an update of CIOMS IV on Benefit-Risk Balance for Marketed Drugs: Evaluation of Safety Signals, originally published in 1998;
- Real-World Data and Real-World Evidence in Regulatory Decision Making (CIOMS XIII);
- Severe Cutaneous Adverse Reactions of Drugs (SCARs).
Download - CIOMS Cumulative Pharmacovigilance Glossary: Version 1.1